Answer
Physicians directing Zavesca (miglustat) treatment should be knowledgeable in managing Gaucher disease or Niemann-Pick type C disease, as appropriate.
Sources for this answer
- Zavesca 100 mg capsules (Great Britain)Janssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.2 Posology and method of administration · Version 30Document updated
Sources checked